BMI

Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total revenue 208.11 M223.54 M238.99 M236.98 M222.27 M 921.79 M Gross profit 82.76 M95.44 M97.81 M95.84 M92.99 M 382.07 M Operating expenses 52.64 M46.01 M52.95 M49.75 M64.64 M 213.35 M Selling/general/admin expenses 43.54 M46.01 M52.95 M49.75 M49.94 M 198.65 M Research & development ————— — Operating income 39.22 M49.42 M44.86 M46.08 M43.05 M 183.42 M Non-Operating Income, Total ————— — Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses ————— — Unusual income/expense ————— — Pretax income 42.13 M50.79 M45.79 M47.44 M44.64 M 188.66 M Equity in earnings ————— — Taxes 11.42 M12.39 M11.2 M12.37 M11.07 M 47.02 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 30.72 M38.4 M34.58 M35.08 M33.58 M 141.63 M Discontinued operations ————— — Net income 30.72 M38.4 M34.58 M35.08 M33.58 M 141.63 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 30.72 M38.4 M34.58 M35.08 M33.58 M 141.63 M Basic earnings per share (Basic EPS) 1.051.311.181.191.14 4.82 Diluted earnings per share (Diluted EPS) 1.041.31.171.191.14 4.8 Average basic shares outstanding 29.36 K29.38 M29.41 M29.42 M29.4 M 117.61 M Diluted shares outstanding 29.53 K29.56 M29.59 M29.58 M29.57 M 118.3 M EBITDA 41.12 M59.04 M54.55 M56.12 M38.71 M 208.43 M EBIT 33.05 M50.76 M45.76 M47.41 M29.91 M 173.84 M Cost of revenue 122.42 M126.77 M140.28 M139.81 M127.72 M 534.59 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 8.07 M8.28 M8.79 M8.71 M8.8 M 34.58 M